共 142 条
[1]
Fine MJ(1997)A prediction rule to identify low-risk patients with community-acquired pneumonia N Engl J Med 336 243-50
[2]
Auble TE(2007)Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults Clin Infect Dis 44 S27-72
[3]
Yealy DM(2003)Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study Thorax 58 377-82
[4]
Hanusa BH(2006)Japanese Respiratory Society. The JRS guidelines for the management of community-acquired pneumonia in adults: an update and new recommendations Intern Med 45 419-28
[5]
Weissfeld LA(2005)Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia Am J Respir Crit Care Med 171 388-416
[6]
Singer DE(2013)Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary Am J Respir Crit Care Med 187 347-65
[7]
Mandell LA(2015)Bacteraemia and antibiotic-resistant pathogens in community acquired pneumonia: risk and prognosis Eur Respir J 45 1353-63
[8]
Wunderink RG(2013)Prognosis of multi-lobar pneumonia in community-acquired pneumonia: a systematic review and meta-analysis Eur J Intern Med 24 857-63
[9]
Anzueto A(2014)β-lactam/macrolide dual therapy versus β-lactam monotherapy for the treatment of community-acquired pneumonia in adults: a systematic review and meta-analysis J Antimicrob Chemother 69 1441-6
[10]
Bartlett JG(2014)Macrolides and mortality in critically ill patients with community-acquired pneumonia: a systematic review and meta-analysis Crit Care Med 42 420-32